Acrinova AB (publ)
SSE:ACRI-B.ST
7.96 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 147.083 | 130.532 | 101.955 | 109.451 | 94.074 | 87.643 | 83.837 | 31.552 | 5.26 | 4.669 |
| Cost of Revenue
| 46.375 | 41.099 | 29.34 | 30.603 | 29.266 | 25.652 | 23.042 | 9.69 | 0 | 0 |
| Gross Profit
| 100.708 | 89.433 | 72.615 | 78.848 | 64.808 | 61.991 | 60.795 | 21.862 | 5.26 | 4.669 |
| Gross Profit Ratio
| 0.685 | 0.685 | 0.712 | 0.72 | 0.689 | 0.707 | 0.725 | 0.693 | 1 | 1 |
| Reseach & Development Expenses
| -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 9.753 | 16.885 | 14.59 | 14.944 | 12.382 | 11.309 | 8.977 | 5.215 | 1.426 | 0 |
| Selling & Marketing Expenses
| 3.248 | 2.08 | 3.175 | 4.751 | 5.429 | 3.023 | 3.123 | 1.449 | 0 | 0 |
| SG&A
| 13.001 | 18.965 | 17.765 | 19.695 | 17.811 | 14.332 | 12.1 | 6.664 | 1.426 | 0 |
| Other Expenses
| -28.564 | 19.387 | 21.014 | 30.949 | 27.394 | 25.093 | 25.786 | 10.213 | 1.709 | 0 |
| Operating Expenses
| 28.564 | 38.352 | 38.779 | 50.644 | 45.205 | 39.425 | 37.886 | 16.877 | 3.134 | 3.8 |
| Operating Income
| 72.144 | 89.433 | 191.223 | 78.847 | 54.929 | 61.991 | 59.095 | 21.586 | 2.125 | 0.87 |
| Operating Income Ratio
| 0.49 | 0.685 | 1.876 | 0.72 | 0.584 | 0.707 | 0.705 | 0.684 | 0.404 | 0.186 |
| Total Other Income Expenses Net
| -83.039 | 14.052 | -2.859 | -23.323 | -4.631 | -5.867 | -0.901 | 9.744 | -0.83 | -2.166 |
| Income Before Tax
| -10.895 | 103.485 | 188.364 | 55.524 | 50.298 | 40.92 | 58.194 | 22.021 | 26.122 | -1.296 |
| Income Before Tax Ratio
| -0.074 | 0.793 | 1.848 | 0.507 | 0.535 | 0.467 | 0.694 | 0.698 | 4.966 | -0.278 |
| Income Tax Expense
| -18.215 | 24.149 | 35.2 | 12.785 | 9.305 | 7.393 | 12.458 | 3.473 | 0.672 | 0.148 |
| Net Income
| 7.764 | 79.336 | 153.164 | 42.74 | 40.993 | 33.527 | 45.511 | 18.572 | 25.45 | -1.444 |
| Net Income Ratio
| 0.053 | 0.608 | 1.502 | 0.39 | 0.436 | 0.383 | 0.543 | 0.589 | 4.839 | -0.309 |
| EPS
| 0.11 | 1.22 | 3.57 | 2.16 | 1.18 | 1.13 | 1.54 | 0.65 | 3.27 | -0.184 |
| EPS Diluted
| 0.11 | 1.22 | 3.57 | 2.16 | 1.18 | 1.13 | 1.54 | 0.65 | 3.27 | -0.184 |
| EBITDA
| 73.76 | 84.12 | 193.682 | 74.606 | 55.31 | 47.077 | 69.698 | 12.528 | 27.968 | -2.166 |
| EBITDA Ratio
| 0.501 | 0.644 | 1.9 | 0.682 | 0.588 | 0.537 | 0.831 | 0.397 | 5.317 | -0.464 |